TXG Stock Summary and Trading Ideas (10X Genomics | NASDAQ:TXG)

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

What symbol and exchange does 10X Genomics shares trade?

10X Genomics trades on the NASDAQ stock market under the symbol TXG.

What is 10X Genomics stock price doing today?

As of October 7, 2026, TXG stock price declined to $77.51 with 5,587,053 million shares trading.

What is 10X Genomics's Beta?

TXG has a beta of 1.19, meaning it tends to be more sensitive to market movements. TXG has a correlation of 0.05 to the broad based SPY ETF.

How much is 10X Genomics worth?

TXG has a market cap of $10.10 billion. This is considered a Large Cap stock.

How much money does 10X Genomics make?

Last quarter 10X Genomics reported $151 million in Revenue and -$.14 earnings per share. This beat revenue expectation by $4 million and missed earnings estimates by -$.08.

What is the highest and lowest price 10X Genomics traded in the last 3 year period?

In the last 3 years, TXG traded as high as $102.81 and as low as $6.78.

What are the top ETFs holding 10X Genomics?

The top ETF exchange traded funds that TXG belongs to (by Net Assets): ARKK, ARKE, IWM, VTI, ARKG.

Is 10X Genomics (TXG) a good investment?

TXG has outperformed the market in the last year with a return of +513.2%, while the SPY ETF gained +16.7%. In the last 3 month period, TXG beat the market returning +93.8%, while SPY returned +3.6%. However, in the most recent 2 weeks TXG has underperformed the stock market by returning -4.0%, while SPY returned +0.4%.

What are the support and resistance levels for 10X Genomics (TXG)?

TXG support price is $76.45 and resistance is $84.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TXG shares will trade within this expected range on the day.